Nia Therapeutics announced publication in Brain Stimulation of the first in vivo validation of its Smart Neurostimulation ...

Neuropsychiatric disorders, such as depression and ADHD, remain a global health burden, with current treatments often limited by individual variability and insufficient long-term efficacy. In a ...

"Nia Therapeutics publishes first in vivo validation of SNS" was originally created and published by Medical Device Network, ...

Saluda Medical, Inc. (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing ...

Nia Therapeutics announced the publication of the first in vivo validation of its wireless, implantable brain-computer ...

Please provide your email address to receive an email when new articles are posted on . The potential for deep brain stimulation rests in the ability for accurate location of biomarkers. Personalized ...

Professor Gustafson's research is in the areas of neural engineering and neural prostheses. His research interests focus on understanding the systems-level neurophysiology and neural control of pelvic ...

Wireless Smart Neurostimulation System records from 10× more brain sites than current adaptive implants; a large-animal study demonstrates chronic sensing, neural-state decoding, and programmable ...